Research shows that EBAG9 leads to strengthened immune response to cancer
The scientists say that shutting down the EBAG9 gene allows the body to destroy tumour cells earlier and more radically.
List view / Grid view
News
Efficiency of antibodies against Omicron variants declines quickly
Researchers have found that the level of protection against Omicron declines as early as three months after a second vaccination or booster shot.
Monkeypox an international health emergency, WHO declares
The World Health Organization has declared monkeypox a Public Health Emergency of International Concern, the highest level of alert.
Scientists discover an antibody that potentially acts as a therapy against SARS-CoV-2
The scientists found that the neutralising monoclonal antibody protected against SARS-CoV-2 infections in animal experiments.
Using computational modelling to gain insights into flu viruses
Scientists at the University of Pittsburgh have been using computational modelling to understand the body’s immune responses to avian flu.
Researchers create weakened version of SARS-CoV-2 that does not cause illness or death
Scientists have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 laboratories, which makes it more efficient to study the virus, and to identify new treatments.
A new study sheds light onto maternal autoantibody linked to autism
The researchers found predictive protein patterns and links of maternal autoantibody–related autism spectrum disorder in the blood of expecting mothers.
First report from the world’s largest whole genome sequencing effort
Scientists have published a report on the whole genome sequences of 150 thousand participants in the UK biobank.
How to select the best combination of antibodies to treat HIV
A new computer-based approach could help clinicians select the best combinations of broadly neutralising antibodies to treat HIV based on the virus’ genetics, while minimising the risk of the virus escaping treatment.
Screening technique could accelerate and improve mRNA therapies
A new single-cell nanoparticle targeting-sequencing approach can measure the cellular uptake of lipid nanoparticles carrying mRNA therapies.
COVID-19 booster jabs provide protection against Omicron variants
Researchers have found that current vaccine boosters offer sufficient immune protection against severe symptoms from Omicron.
New discovery in cancer progression paves way to combat the disease
Researchers have identified an important gene that could enable more targeted treatment for cancer.
Researchers discover new compounds to potentially combat leukaemia
Researchers from the US have identified several new small molecules that can induce mitophagy in leukaemia cells.
Broadly neutralising antibody protects Syrian hamsters against Omicron variants
Researchers have found that a broadly neutralising antibody displays strong antiviral activities against Omicron BA.1, BA1.1 and BA.2.
Researchers use graphene for same-time, same-position biomolecule isolation and sensing
The study has highlighted an important advance in using graphene for electrokinetic bio-sample processing and analysis.